RAREVSSNDL• 3 Months (Normalized)
RARE vs SNDL (Ultragenyx Pharmaceutical Inc. vs SNDL Inc.)
Showing Closing Date Range from Jun, 19 to Sep, 17, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
RARE Performance $14.5
-50.05%
Ultragenyx Pharmaceutical Inc.
Normalized Baseline0.00%
SNDL Performance $1.36
-2.86%
SNDL Inc.
Normalized Baseline0.00%
Alpha Spread Margin SNDL LEADS
-47.19%
SNDL outperforming by 47.19%
RARESNDL
Spread Trajectory3 Months (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
RARE SNDL
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(62 dates)
| Date | RARE Price | RARE Gain (%) | SNDL Price | SNDL Gain (%) | Spread |
|---|---|---|---|---|---|
| Sep 17, 2026 | $14.50 | -50.05% | $1.36 | -2.86% | -47.19% |
| Sep 16, 2026 | $12.88 | -55.63% | $1.38 | -1.43% | -54.20% |
| Sep 15, 2026 | $13.07 | -54.98% | $1.35 | -3.57% | -51.41% |
| Sep 14, 2026 | $13.61 | -53.12% | $1.37 | -2.14% | -50.98% |
| Sep 11, 2026 | $14.30 | -50.74% | $1.34 | -4.29% | -46.45% |
| Sep 10, 2026 | $14.40 | -50.40% | $1.34 | -4.29% | -46.11% |
| Sep 09, 2026 | $14.31 | -50.71% | $1.40 | +0.00% | -50.71% |
| Sep 08, 2026 | $14.88 | -48.74% | $1.44 | +2.86% | -51.60% |
| Sep 04, 2026 | $15.30 | -47.30% | $1.44 | +2.50% | -49.80% |
| Sep 03, 2026 | $14.85 | -48.85% | $1.41 | +0.71% | -49.56% |
| Sep 02, 2026 | $26.53 | -8.61% | $1.42 | +1.43% | -10.04% |
| Sep 01, 2026 | $25.81 | -11.09% | $1.36 | -2.86% | -8.23% |
| Aug 31, 2026 | $25.21 | -13.16% | $1.37 | -2.14% | -11.02% |
| Aug 28, 2026 | $25.61 | -11.78% | $1.36 | -3.21% | -8.57% |
| Aug 27, 2026 | $26.26 | -9.54% | $1.35 | -3.57% | -5.97% |
Page 1 of 5